Buffett's OxyChem acquisition shows how to invest wisely in an overpriced market. Check out more on BRK.A and OXY stocks here ...

Calix is transitioning from hardware to a software- and platform-based business, driving improved margins and recurring ...

A sharp pullback after a euphoric run leaves Oracle looking more balanced, with reasons to be optimistic and a few arguing for caution.

Business credit bureaus compile payment histories, card and loan performance, and public records into a report on each company.

Down almost 80% from all-time highs, Mattr is an undervalued Canadian stock that could more than double over the next four years.

Traffic flow heading into the capital began to increase around midday today as people returned after the Deepavali ...

Data from Bloomberg as of the close of Oct. 14. Norm has an interest in some of the stocks shown.

Markets are getting jittery after JPMorgan CEO Jamie Dimon pointed to potential cracks in the credit markets following a few regional bank earnings.

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent ...

Transactions increase Royal Gold’s scale, diversification and potential for organic growth, and the strong balance sheet and cash flow of the ...

Pensions could help revive the British economy, but damaging policy changes could undermine the whole concept of pension ...

Mesoblast shares lifted after the biotech issued a quarterly activity and cash flow report, as cell therapy revenue gained, ...